Perillartine

Perillartine

Perillartine

Min.Order / FOB Price:Get Latest Price

1 Gram

FOB Price: USD 66.0000

  • Min.Order :1 Gram
  • Purity: 99%
  • Payment Terms : T/T,Other

Keywords

Perillartine 30950-27-7 99%

Quick Details

  • Appearance:Crystal
  • Application:intermediate
  • PackAge:according to your need for packing
  • ProductionCapacity:1|Metric Ton|Day
  • Storage:Keep in dark place,Inert atmosphere,2-8°C
  • Transportation:sea,air,courier

Superiority:

Perillartine Chemical Properties
Melting point     102°C
Boiling point     293.09°C (rough estimate)
density     1.0203 (rough estimate)
refractive index     1.5200 (estimate)
storage temp.     Keep in dark place,Inert atmosphere,2-8°C
pka    11.45±0.28(Predicted)
color     Very sweet crystals
NIST Chemistry Reference    Perillartine(30950-27-7)
EPA Substance Registry System    1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethenyl)-, oxime, (E)- (30950-27-7)          

Details:

Perillartine Basic information
Product Name:    Perillartine
Synonyms:    1-PERILLALDEHYDE A-ANTIOXIME;1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethenyl)-, oxime, (E)-;1-Cyclohexene-1-carboxaldehyde, 4-isopropenyl-, anti-oxime;1-Perillaldehyde alpha-antioxime;1-perillaldehydealpha-antioxime;4-(1-methylethenyl)-,oxime,(e)-1-cyclohexene-1-carboxaldehyd;4-(1-Methylethenyl)-1-cyclohexene-1-carbaldehyde (E)-oxime;4-Isopropenyl-1-cyclohexene-1-carbaldehyde (E)-oxime
CAS:    30950-27-7
MF:    C10H15NO
MW:    165.23
EINECS:    250-402-7
Mol File:    30950-27-7.mol 

Safety Information
Risk Statements     36/37/38
Safety Statements     26-36/37/39
Toxicity    LD50 orl-rat: 2500 mg/kg AFDOAQ 15,82,51                                               

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View